# OnCo record zentalis-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/zentalis-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "zentalis-pharmaceuticals" ;
  schema:name "Zentalis Pharmaceuticals"@en ;
  schema:description "Zentalis Pharmaceuticals is developing azenosertib, a pill that blocks a cell-cycle checkpoint protein called WEE1, for ovarian cancer that no longer responds to platinum chemotherapy."@en ;
  schema:url <https://onco.cc/companies/zentalis-pharmaceuticals/>, <https://zentalis.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://zentalis.com/>, <https://zentalis.com/science/pipeline/>, <https://www.sec.gov/Archives/edgar/data/1725160/000172516020000006/zentalisq12020earningrel.htm> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/wee1/> ;
  onco:drugs <https://onco.cc/drugs/azenosertib/> .